AlzChem Group AG
ALZCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $554,231 | $540,649 | $542,223 | $422,293 |
| % Growth | 2.5% | -0.3% | 28.4% | – |
| Cost of Goods Sold | $193,506 | $241,717 | $259,499 | $153,955 |
| Gross Profit | $360,725 | $298,932 | $282,724 | $268,338 |
| % Margin | 65.1% | 55.3% | 52.1% | 63.5% |
| R&D Expenses | $10,831 | $11,413 | $10,788 | $9,688 |
| G&A Expenses | $11,935 | $12,731 | $11,354 | $11,169 |
| SG&A Expenses | $31,990 | $33,779 | $39,623 | $29,196 |
| Sales & Mktg Exp. | $20,055 | $21,048 | $28,269 | $18,027 |
| Other Operating Expenses | $239,778 | $0 | -$9,540 | -$8,428 |
| Operating Expenses | $282,599 | $160,765 | $252,157 | $230,796 |
| Operating Income | $78,126 | $143,304 | $61,441 | $38,215 |
| % Margin | 14.1% | 26.5% | 11.3% | 9% |
| Other Income/Exp. Net | -$2,783 | -$95,115 | -$20,159 | -$25,534 |
| Pre-Tax Income | $75,343 | $48,189 | $41,282 | $36,512 |
| Tax Expense | $21,097 | $13,397 | $11,059 | $8,748 |
| Net Income | $54,075 | $34,621 | $30,052 | $27,593 |
| % Margin | 9.8% | 6.4% | 5.5% | 6.5% |
| EPS | 5.31 | 3.4 | 2.97 | 2.72 |
| % Growth | 56.2% | 14.5% | 9.2% | – |
| EPS Diluted | 5.31 | 3.4 | 2.97 | 2.72 |
| Weighted Avg Shares Out | 10,176 | 10,170 | 10,136 | 10,147 |
| Weighted Avg Shares Out Dil | 10,176 | 10,170 | 10,136 | 10,147 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,174 | $321 | $7,695 | $643 |
| Interest Expense | $5,832 | $7,663 | $3,032 | $1,703 |
| Depreciation & Amortization | $26,318 | $25,900 | $25,543 | $24,474 |
| EBITDA | $107,493 | $81,752 | $69,857 | $62,684 |
| % Margin | 19.4% | 15.1% | 12.9% | 14.8% |